Funded Grants

PI Name PI Organization Title Grant Number Sort descending Initiative Program Official
Dandoy, Christopher Eugene

Cincinnati Childrens Hosp Med Ctr
United States

The 11th Annual PTCTC Educational Meeting, The First 100 Days After Stem Cell Transplant 1R13HL173950-01 Goli Samimi, Ph.D., M.P.H.
Agsalda-Garcia, Melissa Anne

University Of Hawaii At Manoa
United States

Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients 1R21CA244078-01 PAR-18-020 (R21 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Beane, Jennifer Ellen

Boston University Medical Campus
United States

PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learning 1R21CA253498-01 Guillermo Marquez, Ph.D.
Lin, Po-Ju

University Of Rochester
United States

Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathy 1R21CA256154-01A1 PAR-20-292 (R21 Clinical Trial Optional) Marge Good, R.N., M.P.H., O.C.N.
Nechiporuk, Alex

Oregon Health & Science University
United States

High-throughput identification of molecular targets responsible for drug-induced peripheral neuropathies. 1R21CA260025-01A1 Rachel Altshuler, Ph.D.
Lee, Richard T

Beckman Research Institute/City Of Hope
United States

A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy 1R21CA260447-01A1 Rachel Altshuler, Ph.D.
Rapaport, Mark Hyman

University Of Utah
United States

Massage for Prostate Cancer-Related Fatigue 1R21CA263453-01 PAR-20-292 (R21 Clinical Trial Optional) Goli Samimi, Ph.D., M.P.H.
Perlis, Michael Lloyd

University Of Pennsylvania
United States

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients 1R21CA270987-01 PAR-20-292 (R21 Clinical Trial Optional) Marge Good, R.N., M.P.H., O.C.N.
Oskeritzian, Carole A

University Of South Carolina At Columbia
United States

Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity 1R21CA274021-01A1 Guillermo Marquez, Ph.D.
Zhu, Yong

Univ Of Arkansas For Med Scis
United States

Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection 1R21CA277412-01A1 Christos Patriotis, Ph.D., M.Sc.